Literature DB >> 24787757

Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT study.

Lorenzo Kiferle1, Roberto Ceravolo2, Martina Giuntini1, Giuseppe Linsalata1, Giulia Puccini3, Duccio Volterrani3, Ubaldo Bonuccelli1.   

Abstract

OBJECTIVE: The pathogenesis of visual hallucinations (VHs) in Parkinson's disease (PD) has been considered multifactorial. In the pathophysiology of VHs a combination of impaired visual processing and attention has been reported. Imaging studies evidenced a role of the primary visual system and visual association areas as well as a dysfunctional activation of frontal areas in the occurrence of VHs. Due to the functional connections between basal ganglia and frontal areas, a role of basal ganglia and of the fronto-striatal circuits in the pathogenesis of VHs may be postulated. Aim of this study is to unveil whether a presynaptic dopamine deficiency at baseline may predict the development of VHs.
METHODS: A group of 18 non demented PD patients with VHs was matched with 18 non demented PD patients without VHs as regards age of onset of disease, disease duration and severity and levodopa equivalent dose. We retrospectively analyzed the (123)I-FP CIT SPECT performed on the two groups at the onset of their disease. The striatal uptake values in the two groups were examined, in order to evaluate nigrostriatal differences between the groups with different behavioral phenotype.
RESULTS: The group of patients with VHs had a significant reduction (p < 0.05) in right caudate uptake values at baseline when compared with patients without VHs. No significant differences were found between the groups regarding left caudate and putaminal uptake values.
CONCLUSIONS: The frontal impairment reported in PD patients with VHs may be due to a right caudate dysfunction, as it is connected to the frontal brain areas via neuronal loops.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Caudate nucleus; Parkinson's disease; SPECT; Visual hallucinations

Mesh:

Substances:

Year:  2014        PMID: 24787757     DOI: 10.1016/j.parkreldis.2014.04.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.

Authors:  Niyatee Samudra; Neepa Patel; Kyle B Womack; Pravin Khemani; Shilpa Chitnis
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

Review 2.  The Cholinergic Brain in Parkinson's Disease.

Authors:  Jacopo Pasquini; David J Brooks; Nicola Pavese
Journal:  Mov Disord Clin Pract       Date:  2021-08-23

Review 3.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

4.  Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Authors:  M A Qamar; A Sauerbier; M Politis; H Carr; P Loehrer; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2017-01-25

5.  Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study.

Authors:  Mei Yuan; Laura Sperry; Norika Malhado-Chang; Alexandra Duffy; Vicki Wheelock; Sarah Farias; Kevin O'Connor; John Olichney; Kiarash Shahlaie; Lin Zhang
Journal:  Brain Behav       Date:  2017-04-14       Impact factor: 2.708

Review 6.  Molecular Imaging of the Dopamine Transporter.

Authors:  Giovanni Palermo; Roberto Ceravolo
Journal:  Cells       Date:  2019-08-10       Impact factor: 6.600

Review 7.  Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management.

Authors:  John O'Brien; John Paul Taylor; Clive Ballard; Roger A Barker; Clare Bradley; Alistair Burns; Daniel Collerton; Sonali Dave; Rob Dudley; Paul Francis; Andrea Gibbons; Kate Harris; Vanessa Lawrence; Iracema Leroi; Ian McKeith; Michel Michaelides; Chaitali Naik; Claire O'Callaghan; Kirsty Olsen; Marco Onofrj; Rebecca Pinto; Gregor Russell; Peter Swann; Alan Thomas; Prabitha Urwyler; Rimona Sharon Weil; Dominic Ffytche
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-25       Impact factor: 10.154

8.  Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine.

Authors:  Sonali Dave; Daniel Weintraub; Dag Aarsland; Dominic H Ffytche
Journal:  Mov Disord Clin Pract       Date:  2019-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.